Trial Profile
A Multicenter, Open Label, Dose Finding Study to Evaluate Efficacy and Safety of Givinostat Administered in Two Different Doses in Patients With Poly JIA Not Adequately Responding to the Standard Treatment.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Givinostat (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Italfarmaco
- 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Additional location added as reported by ClinicalTrials.gov.
- 21 Jun 2012 Actual patient number is 16 according to ClinicalTrials.gov.